A Phase 1b Study of JNJ-75276617 in Combination with AML-Directed Therapies

• Research type

  Research Study

• Full title

  Publication of this data is currently deferred.

• IRAS ID

  1005413

• Contact name

  David Wright

• Contact email

  prderacta@prdgb.jnj.com

• Sponsor organisation

  Publication of this data is currently deferred.

• Eudract number

  2021-003999-14

• Clinicaltrials.gov Identifier

  NCT05453903

• Research summary

  Publication of this data is currently deferred.

• REC name

  North West - Greater Manchester Central Research Ethics Committee

• REC reference

  22/NW/0176

• Date of REC Opinion

  1 Aug 2022

• REC opinion

  Further Information Favourable Opinion